Most laboratories do not start with full GMP requirements. They typically begin in discovery or development, where scientific flexibility is critical, then gradually add controls as products move toward clinical development, QC release testing, and commercial manufacturing. A common misconception is that laboratories must replace their software as they transition into more highly regulated environments. In reality, growth from research and discovery through development, validation, and commercialization can be supported on a single, scalable platform.
In this guide from Molecular Devices, learn more about how SoftMax Pro GxP was designed to accompany laboratories throughout this journey, enabling organizations to progressively strengthen compliance controls as regulatory expectations increase.